MYRF and congenital heart disease: Our subsequent assessment of specific MYRF mutations associated with syndromic disease, including congenital heart defects, took advantage of the high editing efficiencies in medaka using the evoBE4max and ABE8e base editors, precisely inducing nucleotide changes at desired positions in contrast to random indel formation by Cas9 (Cornean et al., 2022).